CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancerESMO OPENIF8.32018-01-0111OAAI
Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancersFUTURE ONCOLOGYIF2.62015-11-127PREAI
RAD51 G172T Polymorphism - a Prognostic Value in Cervical Cancer?EUROPEAN JOURNAL OF CANCERIF7.12012-07-011OAAI
CYP3A4*1B Polymorphism - a Prognostic Value in Ovarian Cancer?EUROPEAN JOURNAL OF CANCERIF7.12011-09-010PREAI
Is MMP-9 Q279R a Possible Marker of Prognostic in Non Small Cell Lung Cancer?EUROPEAN JOURNAL OF CANCERIF7.12011-09-011PREAI
Linking XRCC1 Arg399GIn and GGH-401C>T Polymorphisms to Cervical Cancer RiskEUROPEAN JOURNAL OF CANCERIF7.12011-09-010PREAI
Adenocarcinoma and Squamous Cell Carcinoma of the Cervix: Should They Be Treated Differently?EUROPEAN JOURNAL OF CANCERIF7.12011-09-010PREAI
Role of the MDM2 SNP309 Polymorphism in the Initiation and Early Age of Onset of Nasopharyngeal CarcinomaMOLECULAR CARCINOGENESISIF3.22010-12-1020PREAI
Prognostic Significance of Telomerase Polymorphism in Non-Small Cell Lung CancerCLINICAL CANCER RESEARCHIF10.22010-07-1425PRE
CXCL12 chemokine genotypes as predictive biomarkers of ovarian cancer outcomeMOLECULAR MEDICINE REPORTSIF3.52008-01-015OAAI
EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patientsJOURNAL OF NEURO-ONCOLOGYIF3.12006-09-208PREAI
A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancerEUROPEAN JOURNAL OF CANCERIF7.12006-05-0158PREAI
Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancerEUROPEAN JOURNAL OF CANCERIF7.12006-05-0141PREAI